Patents by Inventor Susan A. Farr

Susan A. Farr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating decreased cognitive ability
    Patent number: 11969460
    Abstract: Disclosed are methods and compositions for treating cognitive decline in subjects in need. More specifically, disclosed are methods of administrating exogenous adropin to subjects suffering from, or at risk of, cognitive decline. Also disclosed are subjects who would benefit from such treatment and pharmaceutical acceptable compositions comprising adropin, adropin34-76, and derivatives or variations thereof.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: April 30, 2024
    Assignees: Saint Louis University, U.S. Department of Veternas Affairs
    Inventors: Andrew Alistair Butler, Susan Farr, Clemence Girardet
  • METHOD AND COMPOSITIONS FOR TREATING DECREASED COGNITIVE ABILITY
    Publication number: 20220370566
    Abstract: Disclosed are methods and compositions for treating cognitive decline in subjects in need. More specifically, disclosed are methods of administrating exogenous adropin to subjects suffering from, or at risk of, cognitive decline including the aged and those suffering from traumatic brain injury. Also disclosed are subjects who would benefit from such treatment and pharmaceutical acceptable compositions comprising adropin, adropin34-76, and derivatives or variations thereof.
    Type: Application
    Filed: November 12, 2019
    Publication date: November 24, 2022
    Inventors: Andrew Alistair Butler, Susan Farr, Clemence Girardet
  • TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20220218712
    Abstract: Disclosed herein are methods and compositions for the treatment of Alzheimer's disease by administering to a subject in need thereof a selective agonist for the human adenosine A3 receptor (A3AR) subtype. Also disclosed are methods and compositions for prophylactically treating Alzheimer's disease by administering to a subject in need thereof a selective agonist for the human adenosine A3 receptor (A3AR) subtype.
    Type: Application
    Filed: February 25, 2020
    Publication date: July 14, 2022
    Inventors: Daniela Salvemini, Susan A. Farr
  • METHODS AND COMPOSITIONS FOR TREATING DECREASED COGNITIVE ABILITY
    Publication number: 20210252108
    Abstract: Disclosed are methods and compositions for treating cognitive decline in subjects in need. More specifically, disclosed are methods of administrating exogenous adropin to subjects suffering from, or at risk of, cognitive decline. Also disclosed are subjects who would benefit from such treatment and pharmaceutical acceptable compositions comprising adropin, adropin34-76, and derivatives or variations thereof.
    Type: Application
    Filed: June 4, 2019
    Publication date: August 19, 2021
    Inventors: Andrew Alistair Butler, Susan Farr, Clemence Girardet
  • Antisense Modulation Of Amyloid Beta Protein Expression
    Publication number: 20110166197
    Abstract: Antisense nucleic acids, compositions and methods are provided for modulating the expression of an amyloid beta protein (A?P) portion of the amyloid precursor protein (APP) coding sequence. The compositions comprise antisense nucleic acids targeted to nucleic acids encoding amyloid precursor protein. Methods of using these nucleic acids for modulation of amyloid precursor protein expression and for treatment of diseases and conditions associated with expression of the amyloid beta protein portion of the amyloid precursor protein are provided.
    Type: Application
    Filed: February 19, 2009
    Publication date: July 7, 2011
    Applicant: EDUNN BIOTECHNOLOGY, INC.
    Inventors: Thomas Darling, Vijaya B. Kumar, William A. Banks, Susan Farr, John E. Morley